- Weinstein MC, Freedberg KA, Hyle EP, Paltiel AD. Waiting for certainty on Covid-19 antibody tests—at what cost? N Engl J Med. 2020;383(6):e37. doi:https://doi.org/10.1056/NEJMp2017739.
- Woloshin S, Patel N, Kesselheim AS . False negative tests for SARS-CoV-2 infection—challenges and implications. N Engl J Med. 2020;383(6):e38. doi:https://doi.org/10.1056/NEJMp2015897.
- Sullivan PS, Sailey C, Guest JL, et al. Detection of SARS-CoV-2 RNA and antibodies in diverse samples: protocol to validate the sufficiency of provider-observed, home-collected blood, saliva, and oropharyngeal samples. JMIR Public Health Surveill. 2020;6(2):e19054. doi:https://doi.org/10.2196/19054.
- Tang Y-W, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol. 2020;58(6):e00512. doi:https://doi.org/10.1128/JCM.00512-20.
- Tu Y-P, Jennings R, Hart B, et al. Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med. 2020;383(5):494–496. doi:https://doi.org/10.1056/NEJMc2016321.
- Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206. doi:https://doi.org/10.1111/joim.13091.
- Zainol Rashid Z, Othman SN, Abdul Samat MN, Ali UK, Wong KK. Diagnostic performance of COVID-19 serology assays. Malays J Pathol. 2020;42(1):13–21.
- Gronvall G, Connell N, Kobokovich A, et al. Developing a National Strategy for Serology (Antibody Testing) in the United States. Baltimore, MD: The Johns Hopkins Center for Health Security; 2020.
- Ghaffari A, Meurant R, Ardakani A. COVID-19 serological tests: how well do they actually perform? Diagnostics. 2020;10(7):453. doi:https://doi.org/10.3390/diagnostics10070453.
- Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564–1581. doi:https://doi.org/10.1111/all.14364.
- Yu HQ, Sun BQ, Fang ZF, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020;56(2):2001526. doi:https://doi.org/10.1183/13993003.01526-2020.
- Kobokovich A, West R, Gronvall G. Serology-Based Tests for COVID-19. Baltimore, MD: The Johns Hopkins Center for Health; 2020. https://www.centerforhealthsecurity.org/resources/COVID-19/serology/Serology-based-tests-for-COVID-19.html.
- Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): current status, challenges, and countermeasures. Rev Med Virol. 2020;30(3):e2106. doi:https://doi.org/10.1002/rmv.2106.
- Castro R, Luz PM, Wakimoto MD, Veloso VG, Grinsztejn B, Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Braz J Infect Dis. 2020;24(2):180–187. doi:https://doi.org/10.1016/j.bjid.2020.04.003.
- Bundschuh C, Egger M, Wiesinger K, et al. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma. Clin Chim Acta. 2020;509:79–82. doi:https://doi.org/10.1016/j.cca.2020.05.047.
- Egger M, Bundschuh C, Wiesinger K, et al. Comparison of the Elecsys Anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma. Clin Chim Acta. 2020;509:18–21. doi:https://doi.org/10.1016/j.cca.2020.05.049.
- Traugott M, Aberle SW, Aberle JH, et al. Performance of severe acute respiratory syndrome coronavirus 2 antibody assays in different stages of infection: comparison of commercial enzyme-linked immunosorbent assays and rapid tests. J Infect Dis. 2020;222(3):362–366. doi:https://doi.org/10.1093/infdis/jiaa305.
- Tuaillon E, Bolloré K, Pisoni A, et al. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients. J Infect. 2020;81(2):e39–e45. doi:https://doi.org/10.1016/j.jinf.2020.05.077.
- Demey B, Daher N, François C, et al. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. J Infect. 2020;81(2):e6–e10. doi:https://doi.org/10.1016/j.jinf.2020.04.033.
- Nicol T, Lefeuvre C, Serri O, et al. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol. 2020;129:104511. doi:https://doi.org/10.1016/j.jcv.2020.104511.
- Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol. 2020;129:104480. doi:https://doi.org/10.1016/j.jcv.2020.104480.
- Haselmann V, Kittel M, Gerhards C, et al. Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples. Clin Chim Acta. 2020;510:73–78. doi:https://doi.org/10.1016/j.cca.2020.07.007.
- Jääskeläinen AJ, Kuivanen S, Kekäläinen E, et al. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation. J Clin Virol. 2020;129:104512. doi:https://doi.org/10.1016/j.jcv.2020.104512.
- Montesinos I, Gruson D, Kabamba B, et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020;128:104413. doi:https://doi.org/10.1016/j.jcv.2020.104413.
- Meschi S, Colavita F, Bordi L, et al. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test. J Clin Virol. 2020;129:104539. doi:https://doi.org/10.1016/j.jcv.2020.104539.
- Bonelli F, Sarasini A, Zierold C, et al. Clinical and analytical performance of an automated serological test that identifies S1/S2-neutralizing IgG in COVID-19 patients semiquantitatively. J Clin Microbiol. 2020;58(9):e01224. doi:https://doi.org/10.1128/JCM.01224-20.
- Serrano MM, Rodríguez DN, Palop NT, et al. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection. J Clin Virol. 2020;129:104529. doi:https://doi.org/10.1016/j.jcv.2020.104529.
- Pérez-García F, Pérez-Tanoira R, Romanyk J, et al. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: a prospective single-center study. J Clin Virol. 2020;129:104473. doi:https://doi.org/10.1016/j.jcv.2020.104473.
- Zhang G, Nie S, Zhang Z, Zhang Z. Longitudinal change of severe acute respiratory syndrome coronavirus 2 antibodies in patients with coronavirus disease 2019. J Infect Dis. 2020;222(2):183–188. doi:https://doi.org/10.1093/infdis/jiaa229.
- Shen B, Zheng Y, Zhang X, et al. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG. Am J Transl Res. 2020;12(4):1348–1354.
- Wu JL, Tseng WP, Lin CH, et al. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2. J Infect. 2020;81(3):435–442. doi:https://doi.org/10.1016/j.jinf.2020.06.023.
- Chew KL, Tan SS, Saw S, et al. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection. Clin Microbiol Infect. 2020;26(9):1256.e9–1256-e11. doi:https://doi.org/10.1016/j.cmi.2020.05.036.
- Deeks JJ, Dinnes J, Takwoingi Y, et al.; Cochrane COVID-19 Diagnostic Test Accuracy Group. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6:CD013652. doi:https://doi.org/10.1002/14651858.CD013652.
- European Commission. Guidelines on COVID-19 in Vitro Diagnostic Tests and Their Performance. April 15, 2020. https://ec.europa.eu/info/sites/info/files/testing_kits_communication.pdf.
- Centers for Disease Control and Prevention. Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings. Atlanta, GA: CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html.
- American Association for Clinical Chemistry. AACC Recommendations for SARS-CoV-2 Serology Testing. Washington, DC: AACC; 2020. https://www.aacc.org/science-and-practice/statements-on-covid-19-testing/aacc-recommendations-for-sars-cov-2-serology-testing.
- Infectious Diseases Society of America. IDSA COVID-19 Antibody Testing Primer. Arlington, VA: IDSA; 2020. https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-covid-19-antibody-testing-primer.pdf.
Free access
Antibody tests for COVID-19
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.